STAT3 and osteosarcoma: In summary, the study demonstrated that miR-506-3p could inhibit JAK2/STAT3 signaling pathway by directly binding STAT3, thus reversed the malignant biological behaviors such as proliferation, migration and invasion of drug-resistant osteosarcoma cells, promoted cell apoptosis, as well as inhibited the expressions of drug-resistant proteins.